Health News // 2 days ago
FDA declines to approve first needle-free option to EpiPen
Federal regulators have declined to approve the first needle-free epinephrine treatment for people who suffer from severe allergic reactions, requesting its developer, ARS Pharmaceuticals, to conduct further testing.